CLINICAL AND PATHOLOGICAL SIGNIFICANCE OF THE C-ERBB-2 (HER-2/NEU) ONCOGENE

被引：0
|
作者：
SINGLETON, TP [1 ]
STRICKLER, JG [1 ]
机构：
[1] MAYO CLIN & MAYO FDN, DEPT PATHOL, SURG PATHOL SECT, ROCHESTER, MN 55905 USA
来源：
PATHOLOGY ANNUAL | 1992年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：165 / 190
页数：26
相关论文
共 50 条
  • [1] THE EXPRESSION OF C-ERBB-2 (HER-2/NEU) ONCOGENE IN INVASIVE OVARIAN MALIGNANCIES
    MAKAR, AP
    HOLM, R
    KRISTENSEN, GB
    NESLAND, JM
    TROPE, CG
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (03) : 194 - 199
  • [2] EXPRESSION OF THE HER-2/NEU/C-ERBB-2 ONCOGENE IN BREAST-CANCER
    PRESS, MF
    GODOLPHIN, W
    SLAMON, DJ
    LABORATORY INVESTIGATION, 1989, 60 (01) : A73 - A73
  • [3] AMPLIFICATION OF THE C-erbB-2(HER-2/neu) PROTO-ONCOGENE IN OVARIAN CARCINOMAS
    樊庆泊
    卞美璐
    刘文淑
    黄尚志
    马佳
    郎景和
    许秀英
    中华医学杂志(英文版), 1994, (08) : 31 - 35
  • [4] AMPLIFICATION OF THE C-erbB-2(HER-2/neu) PROTO-ONCOGENE IN OVARIAN CARCINOMAS
    樊庆泊
    卞美璐
    刘文淑
    黄尚志
    马佳
    郎景和
    许秀英
    Chinese Medical Journal, 1994, (08)
  • [5] THE NEU (C-ERBB-2) ONCOGENE
    MAGUIRE, HC
    GREENE, MI
    SEMINARS IN ONCOLOGY, 1989, 16 (02) : 148 - 155
  • [6] c-erbB-2(HER-2/neu)与乳腺癌
    吴强
    临床与实验病理学杂志, 2005, (01) : 6 - 9
  • [7] HER-2/neu (c-erbB-2) Expression Assessment in Breast Cancer
    Ioanid, N.
    Anton, E.
    Socolov, Demetra
    GINECO RO, 2009, 5 (01): : 43 - 47
  • [8] AMPLIFICATION OF THE C-ERBB-2(HER-2/NEU) PROTOONCOGENE IN OVARIAN CARCINOMAS
    FAN, QB
    BIAN, ML
    HUANG, SZ
    LANG, JH
    MA, J
    LIU, WS
    XU, XY
    CHINESE MEDICAL JOURNAL, 1994, 107 (08) : 589 - 593
  • [9] Prognostic significance of c-erbB-2 (HER-2/neu) oncoprotein in benign and malignant breast tumor tissue
    Simícková, M
    Pecen, L
    Cernoch, M
    Vagunda, V
    Pochmon, D
    Vermousek, I
    Lang, B
    Pacovsky, Z
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (04): : 13 - 22
  • [10] CLINICAL-SIGNIFICANCE OF ERBB-2 (HER-2/NEU) PROTEIN
    PAIK, SM
    CANCER INVESTIGATION, 1992, 10 (06) : 575 - 579
12345